Company intelligence / Profile preview

R2M Pharma

South San Francisco, California, United Statesr2mpharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

R2M Pharma is a collaborative pharmaceutical research organization specializing in the discovery and preclinical development of high-quality small molecules for unmet medical needs. The company partners with biotech firms to support target validation, compound optimization, DMPK studies, and patent strategy. It has contributed to advancing multiple clinical candidates in oncology, immunology, and metabolic diseases but does not appear to have its own clinical-stage assets.

Therapeutic areas: OncologyMetabolic DisordersImmunology
Modalities: Small molecule
Industry: Drug Discovery Services

Drug pipeline

1 asset

TN-301

Pre-clinical

Indications: Heart failure

Partnerships

Tenaya Therapeutics (client/partner for lead optimization)Other undisclosed biotech clients

Beyond the preview

Go deeper on R2M Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on R2M Pharma.

Explore the full profile